PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α
作者： Lu Han , Wen-Jun Shen , Stefanie Bittner , Fredric B Kraemer , Salman Azhar
关键词:
摘要: … new dual or pan agonists with combined properties of any of the … activation of PPAR-α also has been shown to attenuate the … some PPAR-α and PPARγ agonists interact with other non-…
futuremedicine.com
sci-hub.se 参考文章(158)
Joshua P. Gray, Katherine A. Burns, Tara L. Leas, Gary H. Perdew, John P. Vanden Heuvel, Regulation of Peroxisome Proliferator-Activated Receptor α by Protein Kinase C† Biochemistry. ,vol. 44, pp. 10313- 10321 ,(2005) , 10.1021/BI050721G
Xian-sheng Huang, Shui-ping Zhao, Lin Bai, Min Hu, Wang Zhao, Qian Zhang, Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-α British Journal of Pharmacology. ,vol. 158, pp. 706- 712 ,(2009) , 10.1111/J.1476-5381.2009.00350.X
Gordon A. Francis, Jean-Sébastien Annicotte, Johan Auwerx, PPAR-α effects on the heart and other vascular tissues American Journal of Physiology-heart and Circulatory Physiology. ,vol. 285, ,(2003) , 10.1152/AJPHEART.01118.2002
Emily L. Abbot, James G. McCormack, Christine Reynet, David G. Hassall, Kevin W. Buchan, Stephen J. Yeaman, Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells FEBS Journal. ,vol. 272, pp. 3004- 3014 ,(2005) , 10.1111/J.1742-4658.2005.04713.X
Anne Minnich, Nian Tian, Lisa Byan, Glenda Bilder, A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle American Journal of Physiology-endocrinology and Metabolism. ,vol. 280, ,(2001) , 10.1152/AJPENDO.2001.280.2.E270
Yuqing E Chen, Mingui Fu, Jifeng Zhang, Xiaojun Zhu, Yiming Lin, Mukaila A Akinbami, Qing Song, None, Peroxisome Proliferator-Activated Receptors and the Cardiovascular System Vitamins & Hormones. ,vol. 66, pp. 157- 188 ,(2003) , 10.1016/S0083-6729(03)01005-7
David Patsouris, Michael Müller, Sander Kersten, Peroxisome proliferator activated receptor ligands for the treatment of insulin resistance Current opinion in investigational drugs. ,vol. 5, pp. 1045- 1050 ,(2004)
Theodosios D Filippatos, Moses S Elisaf, None, Safety considerations with fenofibrate/simvastatin combination. Expert Opinion on Drug Safety. ,vol. 14, pp. 1481- 1493 ,(2015) , 10.1517/14740338.2015.1056778
Sun Hwa Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Hak Chul Jang, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yong Soo Park, Sang Jin Kim, Dong Seop Choi, Safety and efficacy of lobeglitazone monotherapy in patients with type 2 diabetes mellitus over 52 weeks: An open-label extension study Diabetes Research and Clinical Practice. ,vol. 110, ,(2015) , 10.1016/J.DIABRES.2015.09.009
Mary E. Rinella, Nonalcoholic Fatty Liver Disease: A Systematic Review JAMA. ,vol. 313, pp. 2263- 2273 ,(2015) , 10.1001/JAMA.2015.5370